240 related articles for article (PubMed ID: 29752602)
1. Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World.
Nishida T; Cho H; Hirota S; Masuzawa T; Chiguchi G; Tsujinaka T;
Ann Surg Oncol; 2018 Jul; 25(7):1961-1969. PubMed ID: 29752602
[TBL] [Abstract][Full Text] [Related]
2. Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.
Hølmebakk T; Bjerkehagen B; Hompland I; Stoldt S; Boye K
Br J Surg; 2019 Mar; 106(4):419-426. PubMed ID: 30507040
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and Prognostic Analysis of Primary Gastrointestinal Stromal Tumor Presenting with Gastrointestinal Bleeding: a 10-Year Retrospective Study.
Yin Z; Gao J; Liu W; Huang C; Shuai X; Wang G; Tao K; Zhang P
J Gastrointest Surg; 2017 May; 21(5):792-800. PubMed ID: 28275959
[TBL] [Abstract][Full Text] [Related]
4. Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients.
Chok AY; Goh BK; Koh YX; Lye WK; Allen JC; Quek R; Teo MC; Chow PK; Ong HS; Chung AY; Wong WK
Ann Surg Oncol; 2015 Oct; 22(11):3597-605. PubMed ID: 25652053
[TBL] [Abstract][Full Text] [Related]
5. Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.
Hølmebakk T; Hompland I; Bjerkehagen B; Stoldt S; Bruland ØS; Hall KS; Boye K
Ann Surg Oncol; 2018 May; 25(5):1133-1139. PubMed ID: 29435684
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Outcomes and Prognosis of Elderly Patients (≥ 65 Years) with Gastric Gastrointestinal Stromal Tumors (GISTs) Undergoing Curative-Intent Resection: a Multicenter Data Review.
Yang Z; Feng X; Zhang P; Chen T; Qiu H; Zhou Y; Du C; Yin X; Pan F; Zheng G; Liu X; Huang C; Zhou Z; Li G; Tao K; Li Y
J Gastrointest Surg; 2019 May; 23(5):904-913. PubMed ID: 30324400
[TBL] [Abstract][Full Text] [Related]
8. Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy.
Yanagimoto Y; Takahashi T; Muguruma K; Toyokawa T; Kusanagi H; Omori T; Masuzawa T; Tanaka K; Hirota S; Nishida T
Gastric Cancer; 2015 Apr; 18(2):426-33. PubMed ID: 24853473
[TBL] [Abstract][Full Text] [Related]
9. Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.
Xie W; Xiao H; Luo J; Zhao L; Jin F; Ma J; Li J; Xiong K; Chen C; Wang G
Curr Probl Cancer; 2020 Dec; 44(6):100593. PubMed ID: 32507364
[TBL] [Abstract][Full Text] [Related]
10. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
Li XQ; Tu L; Wang M; Ma XL; Yang LX; Shen YY; Zhuang C; Zhao WY; Qiu JF; Zhao G; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):872-879. PubMed ID: 32927512
[No Abstract] [Full Text] [Related]
12. What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture?
Lu J; Dai Y; Zheng HL; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
Medicine (Baltimore); 2019 Jan; 98(3):e14177. PubMed ID: 30653164
[TBL] [Abstract][Full Text] [Related]
13. Assessing prognostic factors of long-term survival after surgery for colorectal gastrointestinal stromal tumours.
Yang S; Maspero M; Holubar SD; Hull TL; Lightner AL; Valente MA; Gorgun E; Kalady MF; Steele SR; Liska D
Colorectal Dis; 2023 Dec; 25(12):2325-2334. PubMed ID: 37876119
[TBL] [Abstract][Full Text] [Related]
14. Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study.
Hohenberger P; Bonvalot S; van Coevorden F; Rutkowski P; Stoeckle E; Olungu C; Litiere S; Wardelmann E; Gronchi A; Casali P
Eur J Cancer; 2019 Oct; 120():47-53. PubMed ID: 31479947
[TBL] [Abstract][Full Text] [Related]
15. [A multicentre retrospective cohort study of patients with gastrointestinal stromal tumors in Shandong Province].
Ning L; Yan W; Zhang M; Gong H; Dai Y; Jiang L; Lin H; Zhang D; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):326-30. PubMed ID: 24760638
[TBL] [Abstract][Full Text] [Related]
16. Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG
JAMA Surg; 2020 Jun; 155(6):e200397. PubMed ID: 32236507
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
[TBL] [Abstract][Full Text] [Related]
18. Imatinib therapy after resection of high-risk gastrointestinal stromal tumors in Chinese patients: a median follow-up of 48 months.
Lei C; Zhao B; Wang Q; Ge L; Wang H
J BUON; 2018; 23(2):460-467. PubMed ID: 29745093
[TBL] [Abstract][Full Text] [Related]
19. Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.
Sakamaki K; Funasaka K; Miyahara R; Furukawa K; Yamamura T; Ohno E; Nakamura M; Kawashima H; Hirooka Y; Fujishiro M; Goto H
Sci Rep; 2020 Sep; 10(1):14767. PubMed ID: 32901065
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of positive microscopic margins (R1 resection) in patients with GIST (gastrointestinal stromal tumours): Results of a multicenter European study.
Thibaut F; Veziant J; Warlaumont M; Gauthier V; Lefèvre J; Gronnier C; Bonnet S; Mabrut JY; Regimbeau JM; Benhaim L; Tiberio GAM; Mathonnet M; Regenet N; Chirica M; Glehen O; Mariani P; Panis Y; Genser L; Mutter D; Théreaux J; Bergeat D; Le Roy B; Brigand C; Eveno C; Guillaume P;
Eur J Surg Oncol; 2024 Jun; 50(6):108310. PubMed ID: 38598874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
